These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2859021)

  • 21. Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica.
    Persellin ST; Daniels TM; Rings LJ; Kazmier FJ; Bowie EJ; Hunder GG
    Mayo Clin Proc; 1985 Jul; 60(7):457-62. PubMed ID: 3925247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study.
    Moosig F; Czech N; Mehl C; Henze E; Zeuner RA; Kneba M; Schröder JO
    Ann Rheum Dis; 2004 Jul; 63(7):870-3. PubMed ID: 15194587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymyalgia rheumatica and giant cell arteritis--a difficult diagnosis.
    Jones JG; Hazleman BL
    J R Coll Gen Pract; 1981 May; 31(226):283-9. PubMed ID: 7310759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
    BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
    Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
    Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.
    Berger CT; Rebholz-Chaves B; Recher M; Manigold T; Daikeler T
    Ann Rheum Dis; 2019 Jul; 78(7):1012-1014. PubMed ID: 30670375
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serum amyloid A as a useful index of disease activity in polymyalgia rheumatica].
    Yamane T; Yamauchi H; Abe N; Torio N; Shimada R; Senba T; Imaizumi Y; Nomura T
    Ryumachi; 2003 Jun; 43(3):544-8. PubMed ID: 12910963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with polymyalgia rheumatica: Screening for vasculitis.
    Arévalo Ruales K; Negueroles Albuixech R; Loaiza Gongora J; Grau García E; Ivorra Cortés J; Román Ivorra JA
    Reumatol Clin (Engl Ed); 2020; 16(1):38-41. PubMed ID: 29550251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comment on rule of thumb 14. Polymyalgia].
    Michel BA
    Praxis (Bern 1994); 2011 Jun; 100(12):705-6. PubMed ID: 21656497
    [No Abstract]   [Full Text] [Related]  

  • 30. A longitudinal study of calprotectin in patients with polymyalgia rheumatica or temporal arteritis: relation to disease activity.
    Brun JG; Madland TM; Gran JT; Myklebust G
    Scand J Rheumatol; 2005; 34(2):125-8. PubMed ID: 16095008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
    Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rhizomelic pseudopolyarthritis (polymyalgia rheumatica) and the problem of very high sedimentation rates].
    Saudan Y; Chavannes F
    Helv Med Acta Suppl; 1969; 49():191-5. PubMed ID: 5268893
    [No Abstract]   [Full Text] [Related]  

  • 33. [Polymyalgia rheumatica. Primary symptoms: muscle pain, malaise].
    Nigg C; Naumann UK; Käser L; Vetter W
    Praxis (Bern 1994); 2007 Oct; 96(44):1705-11; quiz 1712-3. PubMed ID: 18018947
    [No Abstract]   [Full Text] [Related]  

  • 34. Temporal arteritis presenting with paresis of the oculomotor nerve, and polymyalgia rheumatica, despite a low erythrocyte sedimentation rate.
    Polák P; Pokorný V; Stvrtina S; Tauchmannova H; Malis F; Rovensky J
    J Clin Rheumatol; 2005 Aug; 11(4):242-4. PubMed ID: 16357769
    [No Abstract]   [Full Text] [Related]  

  • 35. Polymyalgia rheumatica and giant cell arteritis.
    Ettlinger RE; Hunder GG; Ward LE
    Annu Rev Med; 1978; 29():15-22. PubMed ID: 348031
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
    Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
    J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rheumatic polymyalgia and temporal arteritis. Case contribution and bibliographic review].
    Manganelli P; Mercadanti M; Nervetti A; Ambanelli U
    Minerva Med; 1987 Mar; 78(5):287-96. PubMed ID: 3822219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch.
    Blockmans D; Stroobants S; Maes A; Mortelmans L
    Am J Med; 2000 Feb; 108(3):246-9. PubMed ID: 10723979
    [No Abstract]   [Full Text] [Related]  

  • 39. [Thrombocytosis in polymyalgia rheumatica].
    Seyfarth B; Harten P; Löffler H
    Dtsch Med Wochenschr; 1996 Oct; 121(41):1255-60. PubMed ID: 8925762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of remission is difficult due to frequent relapse during tapering steroids in Korean patients with polymyalgia rheumatica.
    Kim HA; Lee J; Ha YJ; Kim SH; Lee CH; Choi HJ; Baek HJ; Lim MJ; Park W; Choi S; Hong YS; Lee YH; Koh BR; Suh CH
    J Korean Med Sci; 2012 Jan; 27(1):22-6. PubMed ID: 22219609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.